Jefferson Capital, Inc. / DE 8-K

What Happened
Jefferson Capital, Inc. filed an 8-K on March 18, 2026 announcing that Class II director Christopher Giles resigned effective immediately to focus on other commitments and as part of the board’s evolution; the resignation was not due to any disagreement with the company. The Board simultaneously appointed Susan Atkins (Class II) and James Pierce (Class III) as directors, effective March 18, 2026.

Key Details

• Christopher Giles resigned as a Class II director, effective March 18, 2026; resignation not due to any disagreement with the company.
• Susan Atkins appointed as a Class II director with a term expiring at the 2027 annual meeting; James Pierce appointed as a Class III director with a term expiring at the 2028 annual meeting.
• Each new director received an option to buy 50,000 shares of common stock: half exercisable at the fair market value on the grant date, half exercisable at (fair market value + $14.00). Options vest in equal annual installments over three years, subject to continued board service.
• No arrangements, family relationships, or reportable related-party transactions were reported in connection with these appointments.

Why It Matters
This filing updates investors on a board change and related compensation for new directors. Board composition can affect corporate governance and oversight; the option grants create potential future share issuance if exercised, which could modestly dilute existing shareholders. The filing also clarifies the resignation was voluntary and not due to disputes with management.